爱尔兰皇家外科医学院人口健康科学部数据中心2022年招聘高级博士后研究员
爱尔兰皇家外科医学院人口健康科学部数据中心2022年招聘高级博士后研究员
爱尔兰皇家外科医学院 (Royal College of Surgeons in Ireland,简称RCSI),位于爱尔兰共和国首都都柏林,成立于1784年,是所私立医学院。
Senior Postdoc Researcher
Royal College Of Surgeons In Ireland
Description
Post Date : 21-Oct-2022 Close Date : 06-Nov-2022
Title : Senior post-doctoral researcher
Department : Data Science Centre, Division of Population Health Sciences, RCSI
Tenure : Specified purpose contract for 1.5 years
Location : Beaux Lane House, St Stephens Green, Dublin
Reporting to : Dr Caitriona Cahir
Salary : Level 2, Point 1 (欧元47,406)
Proposed Start Date : November/December 2022
Project
The DSC has been awarded a Health Research Board (HRB) Secondary Data Analysis (SDA) grant which is investigating the scope and nature of medication-related harm in older populations in Ireland with the Health Service Executive (HSE) National Quality Improvement Team. Medication- related harm can be common in older people and includes medication incidents, errors, adverse drug reactions (ADRs; harmful responses to medicine) and adverse drug events (ADEs; a broader term for injuries related to medicine use). Four inter-related work-packages are proposed using three prospective longitudinal ageing cohorts (Adverse Drug Reactions in an Ageing PopulaTion (ADAPT), Centre for Primary Care Research (CPCR) and The Irish LongituDinal Study of Ageing linked to pharmacy claims data (TILDA-PCRS). Work-package 1, will identify the high-risk medications and risk factors associated with ADR-related hospital admissions, develop risk prediction models, which identify older people at high risk of medication-related harm and compare these models to other existing models. Work-package 2 will establish the adverse health outcomes associated with medication-related harm and validate the newly developed risk prediction models. Work-package 3 will examine the effect of changes in high-risk medication, including discontinuation, switching of therapy or dose changes on reducing medication- related harm. Work-package 4 will explore extending this research internationally and assess the population risk of medication-related harm in Europe.
The role does not require prior knowledge of medications or medication-related harm as the project is managed by a clinical team, who will advise on the clinical interpretation of the data. The applicant should have a keen interest in working with secondary data and developing their statistical and quantitative modelling skills.
Specific duties:
The development of epidemiological and statistical models that identify medication-related harm in older people using secondary data
Review and compare existing epidemiological models on medication-related harm to the newly developed models and their application to the Irish setting using secondary data
Validation of risk prediction models which identify older people at high risk of medication-related harm using secondary data
To examine ways of reducing medication-related harm (discontinuation of medication, switching of therapies, dose changes) by applying epidemiological and statistical models to secondary data
Write up findings for peer-reviewed publications, reports/policy briefs and presentation to HSE and stakeholders with patient and public involvement (PPI) as required
Disseminate study findings at national and international conferences
Qualifications :
The candidate should preferably have a PhD or MSc in Statistics, Epidemiology, Health Service Research or a related quantitative subject. Candidates with a clinical or pharmacy background will also be considered.
Application Process
Please apply online no later than 5pm on the closing date 31st October 2022 with your CV and Covering Letter. Informal Enquiries can be directed to caitrionacahir@rcsi.ie
更多最新博士后招收信息请关注博士后招聘网微信公众号(ID:boshihoujob)
祝君:学业有成、学成归来
声明:凡本网注明“来源:XXX”的文/图等稿件,本网转载出于传递更多信息及方便产业探讨之目的,并不意味着本站赞同其观点或证实其内容的真实性,文章内容仅供参考。如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任。作者如果不希望被转载或者联系转载等事宜,请与我们联系。邮箱:shuobojob@126.com。
微信公众号
关注硕博英才网官方微信公众号
硕博社群
- 博士交流群:32805967
- 北京硕博交流群:290718865
- 上海硕博交流群:79953811
- 天津硕博交流群:290718631
- 重庆硕博交流群:287970477
- 江苏硕博交流群:38106728
- 浙江硕博交流群:227814129
- 广东硕博交流群:227814204
- 湖北硕博交流群:326626252
- 山东硕博交流群:539554015